| 〔1〕Kandt RS. Tuberous sclerosis complex and neurofibromatosis
type1：The two most common neurocutaneous diseases〔J〕.
Neurologic Clinics of North America, 2003, 21（4）：983-
1004.
〔2〕Wataya-Kaneda M, Katayama I. Dissociate expression of
tuberous sclerosis complex 1 product hamartin in a skin
and pulmonary lesion of a tuberous sclerosis complex〔J〕.
Hum Pathol, 2009, 40（3）：430-434.
〔3〕Brodkiewicz A, Marciniak H, Szychot E, et al. Angiomyolipomas,
renal manifestation of tuberous sclerosis complex
in 17-year-old boy--a case report〔J〕. Ann Acad Med
stetin, 2008,54（2）：160-165.
〔4〕Seyam RM, Bissada NK, Kattan S A, et al. Changing
trends in presentation, diagnosis and management of renal
angiomyolipoma：comparison of sporadic and tuberous
sclerosis complex-associated forms〔J〕. Urology, 2008, 72
（5）：1077-1082.
〔5〕Ewalt DH, Diamond N, Rees C, et al. Long-term outcome
of transcatheter embolization of renal angiomyolipomas due
to tuberous sclerosis complex〔J〕. J Urol, 2005, 174（5）：
1764-1766.
〔6〕Winterkorn EB, Daouk GH, Anupindi S, et al. Tuberous
sclerosis complex and renal angiomyolipoma：case report
and review of the literature〔J〕. Pediatr nephrol, 2006, 21
（8）：1189-1193.
〔7〕Harabayashi T, Shinohara N, Katano H, et al. Management
of renal angiomyolipomas associated with tuberous
sclerosis complex〔J〕. J Urol, 2004,171（1）：102-105.
〔8〕EI-Hashemite N, Zhang H, Henske EP, et al. Mutation in
TSC2 and activation of mammalian target of rapamycin
signaling pathway in renal angiomyolipoma〔J〕. Lancet,
2003, 361（9366）：1348-1349.
〔9〕Lendvay TS, Marshall FF. The tuberous selerosis complex
and its highly variable manifestations〔J〕. J Urol, 2003,
169（5）：1635-1642. |
